About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
COMPANY NEWS
Company
News
Suraksha Diagnostic Ltd.
Change Company
BSE Code
544293
ISIN Demat
INE877V01027
Book Value
43.00
NSE Code
SURAKSHA
Dividend Yield %
0.00
Market Cap
16142.43
P/E
46.18
EPS
6.71
Face Value
2
1 Week
1 Month
3 Months
6 Months
1 Year
09-Oct-2025
Suraksha Diagnostic informs about credit rating ...
18-Aug-2025
Suraksha Diagnostic informs about disclosures
09-Aug-2025
Suraksha Diagnostic submits press release
08-Aug-2025
Intimation For Grant Of Employee Stock Options U...
05-Jul-2025
Suraksha Diagnostic launches Genomics Lab in East...
25-Jun-2025
Suraksha Diagnostic informs about disclosure
19-Jun-2025
Suraksha Diagnostic to invest Rs 200 crore to set...
19-Jun-2025
Suraksha Diagnostic informs about disclosure
19-Jun-2025
Suraksha Diagnostic moves up on planning to inves...
10-Apr-2025
Suraksha Diagnostic acquires 63% equity shares in...
07-Mar-2025
Suraksha Diagnostic informs about press release
17-Feb-2025
Suraksha Diagnostic informs about resignation of ...
03-Feb-2025
Suraksha Diagnostic informs about board meeting
26-Dec-2024
Suraksha Diagnostic informs about closure of trad...
21-Dec-2024
Suraksha Diagnostic informs about investors meet
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.